Stay updated with breaking news from Robert Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Enhances financial flexibility through multiple clinical catalysts on MM-120 and MM-402 product candidates – - The Company’s ending 2Q2023 cash and cash equivalents of $116.9 million and... -Today at 07:31 am- MarketScreener
Company Logo MindMed Investor Presentation August 2023 Disclaimer This presentation has been prepared by Mind Medicine Inc. solely for informational purposes. None of... -Today at 05:35 pm- MarketScreener
-inc-logo.png&w=240&h=240&zc=2){kind=logo}
AdvisorShares Investments LLC reduced its position in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 17.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 93,310 shares of the company’s stock after selling 20,127 shares during the […]
Clinical-stage psychedelics biotech MindMed’s (NASDAQ: MNMD) unaudited financial results for the quarter ended June 30, 2023 look like this:
A strong commandant system works, but only if the person selected is wise, not delusional.